BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the UBS Global Life Sciences Conference, being held September 19-20, 2012 at the Grand Hyatt in New York City. Gustav Christensen, President and Chief Executive Officer of Dyax, will present on Thursday, September 20 at 9:00 AM (ET). Mr. Christensen will provide a corporate update regarding the Company’s key value drivers – KALBITOR® and the angioedema franchise, as well as the Licensing and Funded Research Program (LFRP).